# Trade Mark Journal No.2025/039 26 September 2025

## WO0000001875468 (5,42)

Office of origin: United States of America

Date of International Registration:7 August 2025
Date of designation in the UK: 7 August 2025

The mark consists of a stylized eight-point star design followed by "ARCHONBIO", with "ARCHON" in bold font.

International priority date claimed: 7 February 2025 (United States of America) (99033219)

Class 5
  Biological preparations for pharmaceutical purposes; biological preparations for preventing, diagnosing, treating and managing cancer, tumors, and respiratory diseases; biological preparations for use in oncology, immunology, and pulmonology; biological preparations, namely, custom engineered protein-antibody compounds for medical purposes; biologic compounds being a component of biological preparations for cancer, tumors, and respiratory diseases; therapeutic agents for enhancing drug delivery, biodistribution, and cell target engagement.
Class 42
  Research in the fields of biotechnology, biologics, proteins, protein therapeutics, protein design, and antibodies; design, engineering, and development of biologics, proteins, protein therapeutics, protein design, and antibodies; laboratory services for biomanufacturing; drug discovery services.

Archon Biosciences, Inc.

Representative: Karen Won Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C, One Financial Center, Boston MA 02111, UNITED STATES OF AMERICA